Lippod 20mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Lippod 20mg Injection contains liposomal doxorubicin, an anthracycline cytotoxic (chemotherapy) medicine. Its labelling describes it, used alone or in combination, for the treatment of cancer of different parts of the body, helping relieve the symptoms of various cancers. In breast cancer it is described as helping relieve symptoms such as breast lumps and bloody discharge from the nipples. It is described as killing or inhibiting the growth of cancerous cells and preventing their further multiplication. It is described as very potent and toxic, so its risks and benefits should be discussed with the doctor before use.

Active ingredient
Doxorubicin hydrochloride (liposomal)
Strength
20 mg
Dosage form
Dispersion / concentrate for solution for infusion
Therapeutic class
Anthracycline (cytotoxic antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of various types of cancer, used alone or in combination
  • Described for relieving symptoms of breast cancer such as breast lumps and bloody nipple discharge
  • Described as killing or inhibiting the growth of cancerous cells and preventing further multiplication
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Used only as advised by the doctor, strictly following the prescribed dosage
  • Described as very potent and toxic; its risks and benefits should be discussed with the doctor before use
  • Not to be taken without consulting the doctor

Described Side Effects

The labelling emphasises that this is a potent, toxic medicine and its risks should be discussed with the doctor. Reported effects for this class of medicine include nausea, tiredness, hair loss, and low blood cell counts:

  • Nausea and vomiting
  • Tiredness and weakness
  • Hair loss
  • Low blood cell counts

Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • Not to be taken without consulting the doctor
  • The doctor should be informed of any kidney or liver-related problems
  • Described as to be avoided if pregnant or breastfeeding
  • A proper diet should be followed, alcohol avoided, and adequate hydration with water maintained

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains liposomal doxorubicin and is used, alone or in combination, for the treatment of various types of cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as used only as advised by the doctor, who decides the dosage. It is described as very potent and toxic, so its risks and benefits should be discussed with the doctor before use.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services